title: Management of new onset atrial fibrillation.
authors.forename: R L
authors.initials: RL
authors.lastname: McNamara
authors.forename: E B
authors.initials: EB
authors.lastname: Bass
authors.forename: M R
authors.initials: MR
authors.lastname: Miller
authors.forename: J B
authors.initials: JB
authors.lastname: Segal
authors.forename: S N
authors.initials: SN
authors.lastname: Goodman
authors.forename: N L
authors.initials: NL
authors.lastname: Kim
authors.forename: K A
authors.initials: KA
authors.lastname: Robinson
authors.forename: N R
authors.initials: NR
authors.lastname: Powe
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D000925:Anticoagulants / Q000008:administration & dosage*; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D015897:Comorbidity; D003661:Decision Support Techniques; D004452:Echocardiography; D004554:Electric Countershock / Q000379:methods*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D017678:Sex Distribution; D015996:Survival Rate; D013923:Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D001241:Aspirin